NCT02747563

Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination

Evaluation of PSA Blood Levels in Men on Active Surveillance and Men With Benign Prostatic Hyperplasia Prior to and After Digital Rectal Examination

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Kaplan Medical Center · Academic / Other
• Sex: Male
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

Patients with know prostate cancer (PCa) under active surveillance and aged matched controls without evidence of PCa will have a PSA blood test prior to and following standardized digital rectal examination

Detailed description

Patients with know prostate cancer (PCa) under active surveillance (Gleason 6, PSA \< 10 ng/ml) and aged matched controls without evidence of PCa will have a PSA blood test prior to and following standardized digital rectal examination. The change of PSA will be evaluated.

Conditions

• Prostate Cancer

Interventions

Type	Name	Description
OTHER	Blood test (PSA)	Measurement of blood PSA levels

Timeline

• Start date: 2016-05-01
• Primary completion: 2017-05-01
• Completion: 2017-05-01
• First posted: 2016-04-21
• Last updated: 2016-04-21

Locations

1 site across 1 country: Israel